PURPOSE: Intensity-modulated radiation therapy (IMRT) allows greater dose conformity to the tumor target. However, IMRT, especially static delivery, usually requires more time to deliver a dose fraction than conventional external beam radiotherapy (EBRT). The authors have been using a "two-axis dynamic arc therapy" (2A-DAT) technique for prostate cancer treatment to make a concave dose distribution to spare the rectum and bladder while working with limited time and human resources. The objectives of this study were to (1) clinically implement the 2A-DAT technique, (2) evaluate the dosimetry in comparison with IMRT, and (3) analyze the initial treatment outcome. MATERIALS AND METHODS: The 2A-DAT consists of two dynamic arc therapies (DATs) with half rotation around two isocenters each in two separate symmetrical rhombi. Treatment planning is forward and on a trial-and-error basis. Thirty-four patients received 2A-DAT with a median prescribed dose of 70 Gy. RESULTS: Although inferior in dose uniformity, the 2A-DAT provided equivalent sparing of normal structures to IMRT. Daily fraction delivery time for the 34 patients ranged from 6.4 to 9.6 minutes, with an average of 7.4 minutes. Five-year survival and five-year prostate specific autigen (PSA) failure-free survival were 89.3% and 79.5%, respectively. Three patients developed grade 2 proctitis. CONCLUSION: This technique is a possible alternative to IMRT in EBRT of prostate cancer.
PURPOSE: Intensity-modulated radiation therapy (IMRT) allows greater dose conformity to the tumor target. However, IMRT, especially static delivery, usually requires more time to deliver a dose fraction than conventional external beam radiotherapy (EBRT). The authors have been using a "two-axis dynamic arc therapy" (2A-DAT) technique for prostate cancer treatment to make a concave dose distribution to spare the rectum and bladder while working with limited time and human resources. The objectives of this study were to (1) clinically implement the 2A-DAT technique, (2) evaluate the dosimetry in comparison with IMRT, and (3) analyze the initial treatment outcome. MATERIALS AND METHODS: The 2A-DAT consists of two dynamic arc therapies (DATs) with half rotation around two isocenters each in two separate symmetrical rhombi. Treatment planning is forward and on a trial-and-error basis. Thirty-four patients received 2A-DAT with a median prescribed dose of 70 Gy. RESULTS: Although inferior in dose uniformity, the 2A-DAT provided equivalent sparing of normal structures to IMRT. Daily fraction delivery time for the 34 patients ranged from 6.4 to 9.6 minutes, with an average of 7.4 minutes. Five-year survival and five-year prostate specific autigen (PSA) failure-free survival were 89.3% and 79.5%, respectively. Three patients developed grade 2 proctitis. CONCLUSION: This technique is a possible alternative to IMRT in EBRT of prostate cancer.
Authors: A Pollack; G K Zagars; L G Smith; J J Lee; A C von Eschenbach; J A Antolak; G Starkschall; I Rosen Journal: J Clin Oncol Date: 2000-12-01 Impact factor: 44.544
Authors: Cedric X Yu; X Allen Li; Lijun Ma; Dongjun Chen; Shahid Naqvi; David Shepard; Mehrdad Sarfaraz; Timothy W Holmes; Mohan Suntharalingam; Carl M Mansfield Journal: Int J Radiat Oncol Biol Phys Date: 2002-06-01 Impact factor: 7.038
Authors: Alan Pollack; Gunar K Zagars; George Starkschall; John A Antolak; J Jack Lee; Eugene Huang; Andrew C von Eschenbach; Deborah A Kuban; Isaac Rosen Journal: Int J Radiat Oncol Biol Phys Date: 2002-08-01 Impact factor: 7.038
Authors: C Burman; C S Chui; G Kutcher; S Leibel; M Zelefsky; T LoSasso; S Spirou; Q Wu; J Yang; J Stein; R Mohan; Z Fuks; C C Ling Journal: Int J Radiat Oncol Biol Phys Date: 1997-11-01 Impact factor: 7.038
Authors: Alan Pollack; Alexandra L Hanlon; Eric M Horwitz; Steven J Feigenberg; Robert G Uzzo; Gerald E Hanks Journal: J Urol Date: 2004-03 Impact factor: 7.450
Authors: Zvi Symon; Kent A Griffith; P William McLaughlin; Molly Sullivan; Howard M Sandler Journal: Int J Radiat Oncol Biol Phys Date: 2003-10-01 Impact factor: 7.038